CAS: 1672665-49-4
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | PT-2385 REF: IN-DA00ABOZCAS: 1672665-49-4 | 98% | To inquire | Tue 10 Dec 24 |
 | PT-2385 REF: TM-T7848CAS: 1672665-49-4 | 98.69% - 99.55% | 66.00 €~848.00 € | Fri 13 Dec 24 |
 | PT2385 REF: 3D-XRC66549CAS: 1672665-49-4 | Min. 95% | To inquire | Fri 17 Jan 25 |
Ref: IN-DA00ABOZ
| 1g | To inquire | ||
| 5mg | 72.00 € | ||
| 10mg | 119.00 € | ||
| 25mg | 194.00 € | ||
| 50mg | 234.00 € | ||
| 100mg | 528.00 € | ||
| 250mg | 634.00 € |
Estimated delivery in United States, on Tuesday 10 Dec 2024
PT-2385
CAS:1672665-49-4
PT-2385 is a selective HIF-2α inhibitor (Kd<50 nM).
Formula:
C17H12F3NO4S
Purity:
98.69% - 99.55%
Color and Shape:
Solid
Molecular weight:
383.34
Ref: TM-T7848
| 1mg | 66.00 € | ||
| 2mg | 96.00 € | ||
| 5mg | 150.00 € | ||
| 10mg | 253.00 € | ||
| 25mg | 402.00 € | ||
| 50mg | 596.00 € | ||
| 100mg | 848.00 € | ||
| 1mL*10mM (DMSO) | 125.00 € |
Estimated delivery in United States, on Friday 13 Dec 2024
PT2385
CAS:1672665-49-4
PT2385 is a drug that has shown potent antitumor activity in animal models against renal …
Formula:
C17H12F3NO4S
Purity:
Min. 95%
Molecular weight:
383.34 g/mol
Ref: 3D-XRC66549
| 1mg | To inquire | ||
| 5mg | To inquire | ||
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Friday 17 Jan 2025
